Anavex Life Sciences CorporationMost RecentCompany & Industry OverviewsWhy Anavex Life Sciences Stock Is Rising TodayToday, Anavex Life Sciences (AVXL) announced approval from the Australian Human Research Ethics Committee to initiate its Phase 2b/3 trial evaluating investigational therapy ANAVEX2-73 in early Alzheimers’ disease.
Company & Industry OverviewsWhy Anavex Life Sciences Stock Is Rising TodayToday, Anavex Life Sciences (AVXL) announced approval from the Australian Human Research Ethics Committee to initiate its Phase 2b/3 trial evaluating investigational therapy ANAVEX2-73 in early Alzheimers’ disease.
